• Combined Systems for Brain Function Assessment
    From left: Ann Bunnenberg Chief Operating Officer and President, EGI; Don Tucker CEO, EGI and Christine Soden CFO, EGI

News & Views

Combined Systems for Brain Function Assessment

Jan 30 2015

Electrical Geodesics, Inc., a leading neurodiagnostic medical technology company is to supply GES 400 systems for use with ElMindA’s Brain Network Activation (BNA™) platform.

ElMindA is a US and Israel-based company that is engaged in the development, marketing, and distribution of the BNA™ platform, an analysis system that received FDA clearance in 2014 for the assessment of brain function in 14 to 24-years old.  Combining EGI’s non-invasive, multi-channel EEG technology with ElMindA’s signal processing and analysis algorithms, BNA™ measures patterns of brain networks activated during specific brain processes and delivers both quantitative and qualitative insights into brain function and dysfunction.  Using its proprietary database with more than 8,000 datasets, BNA™ can be used by physicians to potentially help identify and manage neurological disorders. 

Don Tucker, CEO of EGI, commented:  “We have worked with ElMindA over a number of years and are pleased that their research efforts have led to the BNA™ system receiving FDA clearance.  ElMindA recognizes the need for the precision dense array EEG provides to enable objective assessment of brain disorders and injuries.  We believe that by working together, we can bring both our technologies into wider clinical use and drive revenues for both companies.”

Under the agreement, EGI agrees to supply and support ElMindA's customers purchasing the BNA™ analysis system with its leading GES 400 dense array EEG systems on pre-determined terms.

“EGI delivers the quality of dEEG data required to support the BNA™ platform,” said Ronen Gadot, CEO of ElMindA. “We are pleased to collaborate with a partner that offers cutting edge, reliable technology, allowing physicians to acquire the level of data needed to deliver BNA™ test reports in a timely and cost-effective manner.  The importance of this technology has been recognized by the Chief Science Officer of Israel, who has granted funding to further develop the BNA™ system for both diagnostic and therapeutic applications.”


Digital Edition

Lab Asia 31.2 April 2024

April 2024

In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...

View all digital editions

Events

Microbiology Society Annual Conference 2024

Apr 08 2024 Edinburgh 2024

analytica 2024

Apr 09 2024 Munich, Germany

ChemBio Finland 2024

Apr 10 2024 Helsinki, Finland

Analytica Anacon India & IndiaLabExpo

Apr 15 2024 Mumbai, India

Analitika Expo 2024

Apr 16 2024 Moscow, Russia

View all events